Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

AMPK Nasal Spray

£26.24£47.48

Buy AMPK Nasal Spray

The AMP-activated protein kinase complex is a sensor of cellular energy levels. AMPK activation is required for the regulation of metabolic activity in the heart, liver, skeletal muscle, pancreas, and adipose tissue.

AMPK Peptide 15ml contains: 2mg
AMPK Peptide 30ml contains: 4mg

Buy 10 and get 10% Discount

468 in stock

Description

Buy AMPK Nasal Peptide Spray New Zealand

This product is intended for research purposes only. To be used by trained professionals only.

Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is another name for AMPK. AMPK is activated in human skeletal muscle and, according to animal research, also in adipose tissue, liver, and possibly other organs by boosting the AMP/ATP ratio during physical activity. The AMPK pathway is engaged to optimise energy generation, which boosts processes like glucose uptake and fatty acid oxidation while decreasing energy-consuming tasks like lipid and protein synthesis. [1]

The AMPK nasal spray peptide has been identified as a master energy sensor and has been discovered to be overactivated in the brains of people suffering from neurodegenerative disorders, implying that it may play a role in these diseases. Modulating the catalytic activity of AMPK has been found to have neuroprotective effects, perhaps tying its role to ageing and the risk of acquiring neurodegenerative disorders. Furthermore, New Zealand studies have found that activating AMPK may alter cellular metabolism and promote autophagy, making it a possible therapeutic target for illnesses such as Alzheimer’s and Parkinson’s [2].

The AMPK peptide has been shown to have anti-inflammatory effects. AMPK activation, for example, appears to improve energy metabolism while suppressing inflammatory responses associated with chronic stress, such as dietary overload [3]. Furthermore, activation of AMPK has been shown to in New Zealand studies to reduce inflammatory pain by decreasing the amount of the proinflammatory cytokine IL-1 in inflamed skin, implying a possible function in pain management. AMPK activation has also been found to decrease vascular inflammation, confirming its function as a potential therapeutic target in the management of inflammatory disorders [4].

AMPK nasal is emerging as a promising therapeutic target for treating diabetes, metabolic syndrome, and CVD (cardiovascular disease), however, further research is needed [5].

 

Shop the full the range of AMPK peptide here.


References:

[1] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2779044/

[2] https://www.sciencedirect.com/ science/article/pii/S00219258 20873062

[3] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3111671/

[4] https://diabetesjournals.org/ diabetes/article/64/12/4285/34746/ AMPK-Suppresses-Vascular-Inflammation-In-Vivo-by

[5] https://pubmed.ncbi.nlm.nih.gov/ 30710062/


Storage: Lyophilised peptides stored below -18°C.

Research use only. Not for human or animal consumption!

AMPK HPLC 2023 Certificates_DIRECT PEPTIDES

 

 

 

 

 

 

 

 


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Peptides website: https://new-zealand.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY AMPK Nasal Spray ONLINE today From New Zealand Direct Peptides

You may also like…